Clinical Pharmacogenomics: Applications in Nephrology.

Area of Science:

• Genomic Medicine
• Clinical Pharmacology
• Nephrology

Background:

• Pharmacogenomics enables precision pharmacotherapy by analyzing genetic variations affecting drug response.
• Healthcare providers increasingly encounter genomic data, necessitating its application in patient care.
• Genetic variations influence drug metabolism, transport, and targets, impacting efficacy and toxicity.

Purpose of the Study:

• To highlight the role of pharmacogenomics in optimizing drug therapy.
• To emphasize the applicability and potential for nephrologists to lead pharmacogenomics implementation.
• To underscore the need for provider education in accessing and utilizing pharmacogenomic resources.

Main Methods:

• Review of pharmacogenomic principles and their clinical applications.
• Identification of high-evidence clinical recommendations in nephrology where pharmacogenomics is relevant.
• Discussion of clinical decision-making processes for integrating genomic data into practice.

Main Results:

• Pharmacogenomic testing identifies genetic variations linked to drug toxicity or poor efficacy.
• Pharmacogenomics aids in selecting optimal medications and adjusting dosages.
• Nephrology practice, involving cardiovascular disease and transplantation, has several established pharmacogenomic guidelines.

Conclusions:

• Pharmacogenomics is crucial for delivering precision medicine across medical specialties.
• Nephrologists are well-positioned to lead the adoption of pharmacogenomics.
• Effective implementation requires provider familiarity with pharmacogenomic resources and decision-making frameworks.